 |
Program:
|
Duration
|
Topic
|
Speaker
|
|
15:30- .16:00
|
Registration, Coffee
and Vendors Exhibits
|
|
16:00 – 16:15
|
President Welcome
|
Dr.
Raphy Bar
BR Consulting
Pharma and Bio-Pharma
|
|
16:15– 16:30
|
Treasurer Report
|
Karin Baer
Omrix
Biopharmaceuticals Ltd.
|
|
16:30 – 17:15
|
Roadmap
of Drug Development:
From
the chemical to the clinical
|
Dr. Yafit Stark
VP and Chief Clinical Officer
Global Innovative Resources
Teva Ltd.
|
|
17.15 – 18:00
|
How
similar are Biosimilars?
|
Prof.
Yoseph Caraco
Head of Clinical Pharmacology
Unit, Hadassah, Ein-Karem.
|
|
18.00 – 18:45
|
Cocktail Reception and
Vendors Exhibits
|
|
18:45 – 19:15
|
Patents & the
Pharmaceutical Industry: Business
Significance and Strategies
|
Dr.
Ilan Cohn
Reinhold
Cohn & Partners
|
|
19:15 – 20:00
|
Hot
Quality and Regulatory Topics: Update
on International PDA’s
Regulatory and Quality Affairs Committee
|
Karen
Ginsbury
PCI Ltd
|
|
20:00 – 21:00
|
Festive Dinner
|
|
|
|
The evening
will include a festive dinner and
Vendors exhibition with
the opportunity to network with colleagues
from pharmaceutical, biotech and
medical device companies
|
|
|
 Who
should attend:
This promises to be a special meeting addressing
aspects behind and around the "scenes" of
the manufacturing of the finished drug product:
development process, pre-clinical studies,
clinical trials, patent and regulatory affairs
. The meeting is not to be missed and is
suitable for participants from the following
disciplines:
- Research and Development (know your
market requirements)
- Quality Assurance / Compliance
- Quality Control and Laboratories
- Manufacturing
- Regulatory Affairs
- Clinical Trials
- IT
Systems
|
|
|
Participation Fees:
PDA
members - 200 NIS
Non members -
395 NIS |
|
|
|
|
